The Double Burden of Malnutrition Among Adolescents in Low-income and Middle-income Countries

November 14, 2017 updated by: Rishi Caleyachetty, University of Warwick

The Double Burden of Malnutrition Among Adolescents: Analysis of Data From the Global School-Based Student Health and Health Behaviour in School-Aged Children Surveys in 57 Low-income and Middle-income Countries

Individual-participant data analysis of the Global School-Based Student Health Survey and Health Behaviour in School-Aged Children surveys in 57 LMICs between 2003-2013.

Study Overview

Status

Completed

Conditions

Detailed Description

We used the most recent Global School-Based Student Health Surveys (GSHS) and Health Behaviour in School-Aged Children (HSBC) surveys, with data available on height and weight. The GSHS is a World Health Organisation (WHO) initiative, designed to assess health behaviours of adolescents through cross-sectional school-based surveys, across several countries using similar standardised procedures. The HSBC study are WHO sponsored cross-sectional school-based surveys that uses similar standardised procedures to the GSHS to examine the physical and mental health of adolescents in the WHO European Region and North America.

Study Type

Observational

Enrollment (Actual)

129276

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

12 years to 15 years (Child)

Accepts Healthy Volunteers

Yes

Genders Eligible for Study

All

Sampling Method

Probability Sample

Study Population

Adolescents aged 12-15 years from the Global School-Based Student Health Surveys (GSHS) and Health Behaviour in School-Aged Children (HSBC) surveys.

Description

Inclusion Criteria:

  • Low-income or middle-income countries with completed Global School-Based Student Health Survey or Health Behaviour in School-Aged Children surveys.
  • Adolescents aged 12-15 years
  • Recorded sex, height and weight

Exclusion Criteria:

- High-income countries

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Adolescents aged 12-15 years in LMICs
No interventions administered

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Prevalence of stunting
Time Frame: 2003-2013
Trained survey staff measured the height of each student. Stunting was defined as height-for age < 2 standard deviations below the WHO Child Growth Reference median.
2003-2013
Prevalence of thinness
Time Frame: 2003-2013
Trained survey staff measured the weight of each student. Thinness was defined as BMI-for-age < 2 standard deviations below the WHO Growth Reference median. Body mass index [BMI (weight in kilograms divided by height in meters squared)] was calculated from height and weight.
2003-2013
Prevalence of overweight and obesity
Time Frame: 2003-2013
Overweight was defined as BMI-for-age > 1 standard deviation above the WHO Growth Reference median) and obesity was defined as >2 standard deviations above the WHO Growth Reference median.
2003-2013

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Rishi Caleyachetty, MBBS PhD, Warwick Medical School, Warwick University

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

March 1, 2016

Primary Completion (Actual)

March 1, 2017

Study Completion (Actual)

March 1, 2017

Study Registration Dates

First Submitted

November 10, 2017

First Submitted That Met QC Criteria

November 14, 2017

First Posted (Actual)

November 17, 2017

Study Record Updates

Last Update Posted (Actual)

November 17, 2017

Last Update Submitted That Met QC Criteria

November 14, 2017

Last Verified

November 1, 2017

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • WAR2017006203

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Obese

3
Subscribe